<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03631004</url>
  </required_header>
  <id_info>
    <org_study_id>1287/18</org_study_id>
    <nct_id>NCT03631004</nct_id>
  </id_info>
  <brief_title>Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients</brief_title>
  <official_title>Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto do Cancer do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto do Cancer do Estado de São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Olanzapine has been used as prophylactic antiemetic for chemotherapy induced nausea and
      vomiting.

      The project aims to evaluate the efficacy of olanzapine in combination with ondansetron and
      dexamethasone in patients at high risk of postoperative nausea and vomiting, with previous
      history of nausea and vomiting induced by prior chemotherapy, submitted to medium and large
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Double blinded randomized clinical trial. Fifty patients will be selected for each group.
      Group A will receive 10mg olanzapine in the preoperative and group B will receive placebo in
      the preoperative period. Both groups will receive intravenous general anesthesia combined
      with epidural. All patients will receive epidural PCA.

      The primary outcome of this study is the incidence of post-operative nausea and vomiting. The
      power of analysis was based on the following parameters: type error I (α = 0.05), error II (β
      = 0.8), 95% confidence interval and hypothesis test two-tailed. Thus, 42 patients are
      indicated per group to obtain reduction of the incidence of nausea and / or vomiting of the
      population risk from 60% to 30%. The population will be composed of 100 patients because it
      is assumed that percentage of loss of 10% per group.

      The statistical analysis will be performed in program R version 3.5.1. The results obtained
      will be presented as mean + standard deviation for continuous data or absolute frequency for
      described data.

      For quantitative variables, the Student's t-test will be used for with normal distribution or
      Mann-Whitney for non-distributed data normal.

      For qualitative variables, the chi-square test will be used or Fisher's exact test.
      Significant difference is defined as p, 0.05.

      Data will be collected and managed using REDCap data capture tools
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative nausea</measure>
    <time_frame>48 hours</time_frame>
    <description>any episode of nausea</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative vomiting</measure>
    <time_frame>48 hours</time_frame>
    <description>any episode of vomiting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative retching</measure>
    <time_frame>48 hours</time_frame>
    <description>any episode of retching</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>48 hours</time_frame>
    <description>side effects</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Postoperative Nausea</condition>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>olanzapine tablets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PATIENT WILL TAKE OLANZAPINE 10 MG, 1 hour BEFORE SURGERY</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Starch tablets</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PATIENT WILL TAKE PLACEBO 1 hour BEFORE SURGERY</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Olanzapine</intervention_name>
    <description>olanzapine 10 mg is given before surgery</description>
    <arm_group_label>Starch tablets</arm_group_label>
    <arm_group_label>olanzapine tablets</arm_group_label>
    <other_name>Treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients submitted to medium and large surgeries in the thoracic or abdominal region
             (mastectomies, breast plastic, hysterectomies, annexectomies, gynecological pelvic
             surgeries, colectomies, rettosigmoidectomies) under general anesthesia

          -  Patients aged between 18 and 60 years

          -  Patients considered to be at high risk for PONV according to the Apfel scale (Apfel 3
             or 4)

          -  Patients with a history of chemotherapy-induced nausea and vomiting.

        Exclusion criteria:

          -  Pregnancy or Lactation

          -  Current use of typical anti-psychotic medications or atypical

          -  History of allergy to olanzapine

          -  Myocardial infarction or unstable angina in the 6 months prior to the day of surgery
             planning

          -  History of severe ventricular arrhythmia (eg, VT or VF)

          -  Heart Failure Class II or greater second NYHA

          -  Postural hypotension or vasovagal syncope in the 6 months prior to the day of surgery
             planning

          -  Narrow angle glaucoma

          -  Parkinson's disease

          -  Dementia

          -  Inability to swallow medicines

          -  QT interval history greater than 450ms or torsades de pointes

          -  Patient does not want to participate in the study

          -  Videolaparoscopy surgery

          -  Contraindication for neuraxial block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roger Chammas</last_name>
    <role>Study Director</role>
    <affiliation>Instituto do Cancer do Estado de São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela M Sousa</last_name>
    <phone>55 11 38932000</phone>
    <phone_ext>4144</phone_ext>
    <email>angela.sousa@hc.fm.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thiago R Grigio</last_name>
    <phone>+55 11 992981605</phone>
    <email>thiago.grigio@hc.fm.usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cancer Institute of the State of Sao Paulo - ICESP</name>
      <address>
        <city>Sao Paulo</city>
        <state>São Paulo</state>
        <zip>01403010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>angela m sousa, phD</last_name>
      <phone>3893-2000</phone>
      <phone_ext>4144</phone_ext>
      <email>angela.sousa@hc.fm.usp.br</email>
    </contact>
    <contact_backup>
      <last_name>Thiago R Grigio, MsC</last_name>
      <phone>38932000</phone>
      <phone_ext>4144</phone_ext>
      <email>thiago.grigio@hc.fm.usp.br</email>
    </contact_backup>
    <investigator>
      <last_name>Thiago R Grigio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela M Sousa, phD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 11, 2018</study_first_submitted>
  <study_first_submitted_qc>August 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nausea and vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olanzapine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

